Autolus submits confidential filing for U.S. IPO

T cell therapy company Autolus Ltd. (London, U.K.) said on March 5 it submitted a confidential draft registration statement to SEC relating to a potential U.S. IPO. The company said the timing and terms of the IPO have not yet been determined...